Page last updated: 2024-09-05

avasimibe and Elevated Cholesterol

avasimibe has been researched along with Elevated Cholesterol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bocan, TM; Dagle, C; Krause, BR; Lathia, C; Lee, H; Lu, X; Major, T; Mueller, SB; Rosebury, WS1
Brown, WV1

Reviews

1 review(s) available for avasimibe and Elevated Cholesterol

ArticleYear
Therapies on the horizon for cholesterol reduction.
    Clinical cardiology, 2001, Volume: 24, Issue:8 Suppl

    Topics: Acetamides; Acetates; Anticholesteremic Agents; Azetidines; Carrier Proteins; Cholestyramine Resin; Ezetimibe; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxysteroid Dehydrogenases; Hypercholesterolemia; Membrane Glycoproteins; Pyrimidines; Rosuvastatin Calcium; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids

2001

Other Studies

1 other study(ies) available for avasimibe and Elevated Cholesterol

ArticleYear
The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits.
    Arteriosclerosis, thrombosis, and vascular biology, 2000, Volume: 20, Issue:1

    Topics: Acetamides; Acetates; Animals; Anticholesteremic Agents; Aorta, Thoracic; Arteriosclerosis; Base Sequence; Cholesterol; DNA Primers; Enzyme Inhibitors; Gene Expression; Humans; Hypercholesterolemia; Macrophages; Male; Matrix Metalloproteinases; Rabbits; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Tissue Inhibitor of Metalloproteinases

2000